RedHill Biopharma Ltd. Sponsored ADR Stock price
Is RedHill Biopharma Ltd. Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
RedHill Biopharma Ltd. Sponsored ADR Stock Analysis
Analyst Opinions
7 Analysts have issued a RedHill Biopharma Ltd. Sponsored ADR forecast:
Analyst Opinions
7 Analysts have issued a RedHill Biopharma Ltd. Sponsored ADR forecast:
Don't miss a Thing! We will send you all news about RedHill Biopharma Ltd. Sponsored ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
RedHill Biopharma Ltd. Sponsored ADR Stock News
Company Profile
RedHill Biopharma Ltd. is a biopharmaceutical company focusing on the development and commercialization of proprietary drugs for the treatment of gastrointestinal diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company's subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.
| Head office | Israel |
| CEO | Mr. Ben-Asher |
| Employees | 35 |
| Founded | 2009 |
| Website | www.redhillbio.com |


